| Literature DB >> 35251818 |
Ryohei Ushioda1, Tomonori Shirasaka1, Taro Kanamori2, Atsuko Fujii2, Makoto Shirakawa2, Taro Takeuchi2, Hiroyuki Kamiya1.
Abstract
Background The aim of the present study was to compare the clinical outcome of the David operation and the Bentall operation in patients with Stanford type A acute aortic dissection (AADA) from the viewpoint of hemostasis. Methods Between April 2016 and April 2020, 235 patients underwent emergent surgery for AADA. Of them, 38 patients required aortic root replacement (ARR: The David operation 17, the Bentall operation 21). The mean age was 59.3±12.6 years. In the present series, the David operation was the first choice for relatively young people, and the Bentall operation was performed for relatively elderly patients and cases in which valve-sparing seemed impossible. Results Between the David and the Bentall group, the 30-day mortality rate did not differ significantly. However, hemostasis time (144.6±50.3 vs. 212.5±138.1 min, p=0.047), defined as the interval from the cessation of cardio-pulmonary bypass (CPB) to the end of the operation, and total operation time (477.8±85.7 vs. 578.3±173.6 min, p=0.027) were significantly shorter in the David group than in the Bentall group, and the amount of blood transfusion was less in the David group than in the Bentall group (red blood cells: 3.5±3.6 vs. 9.2±5.9 units, p=0.013; fresh frozen plasma: 4.1±4.7 vs 9.4±5.1 units, p=0.002; platelet concentrate: 33.2±11.3 vs 42.2±12.0 units, p=0.025). Conclusion David operation offers a shorter hemostasis time and consequently shorter operation time than the Bentall operation in the setting of AADA, probably due to double suture lines, despite its surgical complexity.Entities:
Keywords: aortic root replacement; bentall procedure; david; hemostasis; type a acute aortic dissection
Year: 2022 PMID: 35251818 PMCID: PMC8888353 DOI: 10.7759/cureus.21747
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Patients’ characteristics and preoperative data
COPD - Chronic obstructive pulmonary disease; PLT - platelet; PT-INR - prothrombin time - international normalized ratio; APTT - activated partial thromboplastin time; FIB - fibrinogen
| Variable | David (n=17) | Bentall (n=21) | P-value |
| Age (y) | 51.4±8.6 | 65.7±12.1 | 0.0001 |
| Male (n) | 14 (82.3%) | 17 (80.9%) | 0.456 |
| Preexisting comorbidities | |||
| Hypertension (n) | 6 (35.3%) | 5 (23.8%) | 0.219 |
| COPD (n) | 0 (0%) | 2 (9.5%) | 0.096 |
| Diabetes mellitus (n) | 1 (5.9%) | 0 (0%) | 0.130 |
| Chronic renal disease (n) | 1 (5.9%) | 2 (9.5%) | 0.340 |
| Hyperlipidemia (n) | 2 (11.7%) | 2 (9.5%) | 0.412 |
| Current smoker (n) | 2 (11.7%) | 5 (23.8%) | 0.170 |
| Malperfusion (n) | 2 (11.7%) | 12 (57.1%) | 0.004 |
| Brain (n) | 0 (0%) | 5 (23.8%) | 0.015 |
| Coronary (n) | 1 (5.9%) | 4 (19.1%) | 0.116 |
| Mesentery (n) | 1 (5.9%) | 0 (0%) | 0.130 |
| Renal (n) | 0 (0%) | 1 (4.7%) | 0.181 |
| Extremities (n) | 0 (0%) | 1 (4.7%) | 0.181 |
| Spinal cord (n) | 0 (0%) | 2 (9.5%) | 0.096 |
| Preoperative Blood Tests | |||
| PLT (x10^4/µL) | 19.28±11.28 | 16.43±5.38 | 0.0023 |
| PT-INR | 1.16±0.25 | 1.29±0.36 | 0.215 |
| APTT (sec) | 35.18±6.97 | 37.45±23.1 | 0.0001 |
| FIB (mg/dL) | 196.71±115.38 | 163.47±88.8 | 0.319 |
| pH | 7.34±0.14 | 7.32±0.11 | 0.239 |
| Lactate (mmol/L) | 3.49±4.40 | 3.97±3.57 | 0.373 |
| Preoperative condition | |||
| Cardiac arrest (n) | 1 (5.9%) | 2 (9.5%) | 0.340 |
| Cardiac tamponade with shock (n) | 2 (11.7%) | 9 (42.8%) | 0.018 |
| Indication for root replacement | |||
| Aortic root rupture (n) | 4 (23.5%) | 6 (28.6%) | 0.363 |
| Entry in the aortic root (n) | 8 (47.1%) | 9 (42.8%) | 0.398 |
| Root enlargement (n) | 12 (70.5%) | 5 (23.8%) | 0.002 |
Operative data
CABG - coronary artery bypass grafting; MVR - mitral valve replacement; CPB - cardiopulmonary bypass; HCA - hypothermic circulatory arrest; RBC - red blood cell; FFP - fresh frozen plasma; PC - packed cell
| Variable | David (n=17) | Bentall (n=21) | P-value |
| Location of primary entry | |||
| Root (n) | 8 (47.1%) | 9 (42.8%) | 0.398 |
| Ascending (n) | 6 (35.3%) | 7 (33.3%) | 0.216 |
| Arch (n) | 4 (23.5%) | 6 (28.6%) | 0.363 |
| Proximal descending | 2 (11.7%) | 2 (9.5%) | 0.412 |
| Extent of replacement | |||
| Ascending | 6 (33.3%) | 9 (42.8%) | 0.318 |
| Partial arch | 6 (35.3%) | 7 (33.3%) | 0.450 |
| Total arch | 5 (29.4%) | 5 (23.8%) | 0.348 |
| Concomitant procedures | |||
| CABG | 2 (11.7%) | 5 (23.8%) | 0.171 |
| MVR | 0 (0%) | 1 (4.8%) | 0.181 |
| Femoro-femoral bypass | 0 (0%) | 1 (4.8%) | 0.181 |
| Operation time (min) | 477.8±85.7 | 578.3±173.6 | 0.027 |
| CPB time (min) | 297.4±56.8 | 336.1±113.2 | 0.182 |
| Myocardial ischemia time (min) | 248.7±61.6 | 257.9±63.6 | 0.655 |
| HCA time (min) | 48.6±21.2 | 45.3±16.4 | 0.603 |
| Hemostasis time (min) | 144.6±50.3 | 212.5±138.1 | 0.047 |
| Bleeding amount (mL) | 1253±545 | 1437±684 | 0.365 |
| Blood transfusion | |||
| RBC (units) | 3.5±3.6 | 9.2±5.9 | 0.013 |
| FFP (units) | 4.1±4.7 | 9.4±5.1 | 0.002 |
| PC (units) | 33.2±11.3 | 42.2±12.0 | 0.025 |
Postoperative outcomes
| Variable | David (n=17) | Bentall (n=21) | P-value |
| ICU stay (days) | 5.1±2.2 | 7.3±5.7 | 0.0001 |
| Hospital stay (days) | 23.1±10.4 | 38.0±27.2 | 0.039 |
| Complications | |||
| Re-thoracotomy for bleeding (n) | 0 (0%) | 0 (0%) | 1 |
| Moderate AR (n) | 1 (5.9%) | 0 (0%) | 0.130 |
| Acute kidney injury requiring dialysis (n) | 0 (0%) | 1 (4.8%) | 0.181 |
| Pericardial effusion requiring drainage (n) | 1 (5.9%) | 4 (19.0%) | 0.116 |
| Respiratory failure requiring tracheotomy (n) | 0 (0%) | 1 (33.3%) | 0.181 |
| Stroke (n) | 0 (0%) | 5 (23.8%) | 0.015 |
| Paraplegia (n) | 0 (0%) | 2 (9.5%) | 0.095 |
| GI bleeding (n) | 0 (0%) | 2 (9.5%) | 0.095 |
| Sepsis (n) | 0 (0%) | 4 (19.0%) | 0.028 |
| 30-day mortality (n) | 2 (11.7%) | 4 (19.0%) | 0.540 |
| In-hospital mortality (n) | 2 (11.7%) | 5 (23.8%) | 0.341 |
Figure 1Survival curve in the David group and Bentall group